Viatris Inc. Common Stock (VTRS) Stock Price, Quote & AI Analysis

Live VTRS stock price, real-time charts, AI-powered trade signals, technical analysis, earnings insights, and market sentiment for Viatris Inc. Common Stock.

TradeVae provides AI-driven analysis and real-time market intelligence for Viatris Inc. Common Stock (VTRS), including price action, technical indicators, earnings performance, analyst sentiment, and short-term trade setups.

VTRS
Viatris Inc. Common Stock
real-time
$0.00 +0.00 (+0.00%)
Open
13.050000
High
13.680000
Low
13.000000
Volume
10,130,653
VWAP
-
Market Cap
$15,076,667,624.48
52W Range
$6.85 - $13.68
P/E Ratio
-
EPS
-
Dividend Yield
366.69%
Debt/Equity
-
EV/EBITDA
-
Upcoming Earnings
Feb 25, 2026 Q4
After Hours
EPS Estimate: $0.546
Revenue Estimate: $3,609,473,796.00
Loading chart...

AI Analysis

Explore comprehensive AI-powered analysis including summary insights, bull and bear cases, key risks, and factors to watch.

Loading...

Generating AI analysis...

-
-
-
-

Viatris Inc. Common Stock's fundamentals reflect its scale, profitability, and position within the global technology sector. Key valuation and financial metrics are summarized below, followed by detailed financial statements.

Viatris Inc. Common Stock Overview

Company information

Company Overview

Viatris, Inc. is a global healthcare company, which engages in the provision of healthcare and pharmaceutical products. It provides medicines and treatments in various therapeutic areas such as cardiovascular, oncology, dermatology, eye care, gastroenterology, immunology, and women's healthcare. The firm operates through the following segments: Developed Markets, Greater China, JANZ, and Emerging Markets. The Developed Markets segment consists of operations primarily in North America and Europe. The Greater China segment includes operations in mainland China, Taiwan, and Hong Kong. The JANZ segment covers operations in Japan, Australia, and New Zealand. The Emerging Markets segment encompasses operations in developing markets and emerging economies including in Asia, the Middle East, South and Central America, Africa, and Eastern Europe. The company was founded on February 14, 2019 and is headquartered in Canonsburg, PA.

Company Details
Market Cap
$15.75B
Shares Outstanding
1,151,770,000
Weighted Shares Outstanding
1,151,769,872
CEO
Scott Andrew Smith
Address
1000 MYLAN BOULEVARD, CANONSBURG, PA, 15317
Employees
30,000
Industry
PHARMACEUTICAL PREPARATIONS
Exchange
XNAS

Technical Indicators

Key technical analysis metrics and signals

Loading...

Loading technical indicators...

Valuation Metrics

Key valuation ratios and comparisons

Loading...

Loading valuation metrics...

Viatris Inc. Common Stock Earnings & Financial Statements

Earnings Calendar

Upcoming earnings dates and historical surprises

Loading...

Loading earnings calendar...

Financial Statements

Income statements, balance sheets, and cash flow

Loading...

Loading income statements...

Loading...

Loading balance sheets...

Loading...

Loading cash flow statements...